TAT-HA2 Fusion Peptide – 1 mg

Overview

The TAT-HA2 Fusion Peptide is an innovative product designed for advanced research in drug delivery systems. This peptide consists of amino acids 1 to 20 of the influenza A virus hemagglutinin protein (HA2), which is linked to a 10 amino acid cell permeable HIV Trans-Activator of Transcription (TAT) protein transduction domain (PTD). The result is a powerful tool that enhances cellular uptake and can be utilized effectively in macromolecule drug delivery applications.

Key Features

• Cell permeable TAT PTD for effective membrane penetration.
• Enhanced endosomal escape due to the HA2 domain’s pH sensitivity.
• Ideal for large macromolecule delivery in therapeutic research.
• Utilizes lipid raft-dependent macropinocytosis for improved transduction.
• Available in 1 mg quantities, ensuring convenience for varied research needs.

Specifications

FAQ

What applications can TAT-HA2 Fusion Peptide be used for?

The TAT-HA2 Fusion Peptide is primarily used for drug delivery studies and can facilitate the introduction of large molecules into cells for therapeutic research.

How does the TAT PTD enhance cellular uptake?

The TAT PTD penetrates cell membranes through lipid raft-dependent macropinocytosis, allowing for efficient delivery of therapeutic agents directly into the cell.

Is there a recommended storage condition for this peptide?

It is advisable to store the TAT-HA2 Fusion Peptide at -20°C to maintain its stability and efficacy over time.

By incorporating the TAT-HA2 Fusion Peptide into your research, you can take advantage of its unique properties for enhanced macromolecule delivery. For more peptide options, explore our wide range of peptides to find what best suits your experimental needs. Don’t miss the opportunity to enhance your research capabilities; shop now and experience the difference.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled